Clinical Trial Results:
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Assess the Safety and Efficacy of TWO Weeks of Oral Senicapoc Administration on Allergen challenge in Atopic Asthmatic Subjects.
Summary
|
|
EudraCT number |
2008-004152-71 |
Trial protocol |
GB |
Global completion date |
21 May 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Dec 2016
|
First version publication date |
28 Dec 2016
|
Other versions |
|
Summary report(s) |
ICA 17043-17 Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.